A pharmaceuticals health care company.
Issues related to corporate tax reform. Development of legislation regulated to regulation of LDT's, including a discussion draft of Diagnostic Accuracy and Improvement Act.

Issues related to WHO and diagnostic tests.

H.R. 1628: American Health Care Act of 2017.

H.R.2430: FDA Reauthorization Act of 2017. Medicare quality measures related to malnutrition among older Americans.  

Implementation of PAMA (Protecting Access to Medicare Act of 2014).
TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX